Research Protocols / Healing
BPC-157 and TB-500 blend: two mechanisms, one vial
The pairing is common because the two peptides converge on tissue repair through genuinely different routes. Understanding which does what is the difference between a designed experiment and a guess.
Blended vials are convenient and slightly risky. Convenient because two lyophilized peptides in one cake reconstitute together and stay lot-matched. Risky because a blend certificate has to resolve two compounds in one chromatogram, and a supplier who cannot show you that separation is asking for trust they have not earned. Start with the mechanisms, then the verification.
Two different repair mechanisms
| BPC-157 | TB-500 | |
|---|---|---|
| Origin | Synthetic 15-residue fragment of a gastric protective protein | Synthetic fragment of Thymosin Beta-4, a 43-residue actin-binding protein |
| Primary studied mechanism | Angiogenic signalling, VEGFR2 pathway activation, fibroblast migration | G-actin sequestration, actin cytoskeleton remodelling, cell migration |
| Tissue emphasis in literature | Tendon, ligament, gastrointestinal mucosa | Muscle, cardiac tissue, dermal wound models |
| Structural class | Short linear peptide | Actin-binding domain fragment |
The complementarity is real rather than marketing. BPC-157 research centres on vascular supply and fibroblast behaviour, the plumbing and the builders. TB-500 research centres on actin dynamics that permit cells to migrate into a wound bed at all. A repair model that is limited by perfusion and a model limited by cell migration are different experiments, and the blend lets you address both axes with lot-matched material.
If you are studying one mechanism specifically, use the single-compound vials. The blend is for repair models where you want both axes covered and are not trying to attribute the effect to one pathway.
Ratio and concentration math
Our blend ships as a 10 mg combined vial at 99.12% HPLC purity on the current lot. The critical arithmetic point: the total mass is the sum of both peptides, so a 10 mg blend vial does not contain 10 mg of each compound. Compute per-compound concentration from the ratio stated on the lot certificate.
| Water added to 10 mg blend | Total blend concentration | Per 0.1 mL draw |
|---|---|---|
| 2 mL | 5 mg/mL total | 500 mcg total peptide |
| 5 mL | 2 mg/mL total | 200 mcg total peptide |
For a 1:1 blend, halve those totals to get per-compound mass. Comparing a blend result against published single-compound data without doing this conversion is the most common error in blend protocols.
Verification is harder for blends, so it matters more
A single-compound COA shows one dominant peak. A blend COA must show two resolved peaks, each integrated, with the ratio between them reported. If the two compounds co-elute, meaning the column could not separate them, the certificate cannot substantiate the ratio and you are trusting the manufacturer's mixing step with no analytical check.
Read the chromatogram, not just the summary line. Our chromatogram reading guide covers peak resolution and integration. The current blend lot certificate is posted at Lab Results, alongside the certificates for the single BPC-157 and single TB-500 vials if you want to cross-check retention times against pure standards. That cross-check, running the blend against two single-compound reference chromatograms, is the most rigorous verification available to a buyer and it costs nothing but attention.
Storage and stability
Blends follow the same handling rules as their components. Lyophilized and sealed under nitrogen, the vial is stable at minus 20 degrees Celsius for the shelf life stated on the certificate. Once reconstituted with bacteriostatic water, refrigerate at 2 to 8 degrees Celsius and observe the window on the lot certificate. TB-500 fragments are somewhat more freeze-thaw sensitive than short linear peptides like BPC-157, so aliquot the reconstituted blend rather than repeatedly accessing one vial. See the freeze-thaw guide for cycle tolerance by peptide class.
Sourcing and verification
Purity matters more than any protocol detail. A concentration curve computed from a vial that is 88% peptide and 12% truncated sequence is not reproducible, and the failure is invisible until you compare it against another lot. Every Lumera Labs lot ships with a lot-specific certificate of analysis reporting HPLC-UV purity, and those certificates are posted publicly at Lab Results before you order, not emailed afterward. Orders ship from within Canada in 24 to 48 hours, free over $200 CAD, so there is no customs exposure and no multi-week transit window for temperature-sensitive material.
FAQ
Does a 10 mg blend vial contain 10 mg of each peptide?
No. The stated mass is the combined total of both peptides. For a 1:1 blend, a 10 mg vial contains roughly 5 mg of each. Always compute per-compound concentration from the ratio on the lot certificate before comparing against single-compound literature.
Why are BPC-157 and TB-500 studied together?
They converge on tissue repair through different mechanisms. BPC-157 research centres on angiogenic signalling and fibroblast migration; TB-500 research centres on G-actin sequestration and cytoskeletal remodelling that enables cell migration. The blend addresses both axes with lot-matched material.
How should a blend certificate of analysis look?
It should show two resolved peaks, each integrated, with the ratio between them reported. If the two compounds co-elute, the certificate cannot substantiate the ratio analytically. Cross-checking retention times against single-compound reference chromatograms is the strongest verification available.
Should I use the blend or separate vials?
Use separate vials if you need to attribute an effect to one mechanism or vary the ratio. Use the blend for repair models where both axes are wanted and lot-matching between the two compounds is an advantage.
How is the blend stored after reconstitution?
Refrigerate at 2 to 8 degrees Celsius and observe the window on the lot certificate. Aliquot rather than repeatedly accessing one vial, since TB-500 fragments tolerate freeze-thaw less well than short linear peptides.
Continue reading